Psychiatrist escape room
Immerse yourself in a virtual psychiatrist office led by Prof Robert Perneczky. Apply your understanding of biomarkers in Alzheimer’s disease to answer questions, uncover clues, and work through case-based decisions.
Can you gather all the insights needed to make your way out of the clinic?
Liked this educational activity?
General information
Title: Escape the clinic: Psychiatrist escape room
Jointly provided by Postgraduate Institute for Medicine and Springer Health+ IME
Release date: December 22, 2025
Expiration date: December 22, 2026
Estimated time: 15 minutes per escape room
Target audience
This activity is primarily aimed at dementia specialists, neurologists, geriatricians, geriatric psychiatrists, primary care providers, imaging physicians, advanced practice providers (NPs/PAs), but is relevant to all members of the multidisciplinary team that manage patients with Alzheimer’s disease.
Learning objectives
After completing this module, the participant should be better able to:
- Evaluate the utility of current and emerging biomarkers to support an accurate diagnosis of early-stage Alzheimer’s disease
- Interpret the results of imaging and fluid biomarker tests for early-stage Alzheimer’s disease
- Apply biomarker testing to guide treatment selection for disease-modifying therapies and appropriate treatment monitoring
- Establish a shared decision-making approach that prioritizes empathetic and clear communication with patients and caregivers throughout the biomarker testing process
Faculty
Professor Robert Pernezcky
Professor of Translational Dementia Research
LMU Hospital, LMU Munich, Germany
Disclosure of financial relationships
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified financial relationships are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:
Professor Robert Pernezcky
Employee/Owner: Medotrax
Grant/Research Support: GSK, Roche
Speakers Bureau/Honoraria for non-CME: Biogen, Eisai, Eli Lilly, Roche, Schwabe, Tabuk
Consultant/Advisory Board: Biogen, Bristol-Myers Squibb, Eisai, Eli Lilly, Roche
The PIM planners and others have nothing to disclose. The Springer Health+ IME planners and others have nothing to disclose.
All relevant financial relationships have been mitigated.
Joint accreditation statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Springer Health+ IME. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designations
All credits are listed per escape room.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™
(per specialty room completed).
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 0.25 contact hours (per specialty room completed).
Continuing Physician Assistant Education
The Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 CME credits per specialty room completed. Approval is valid until December 22, 2026. PAs should only claim credit commensurate with the extent of their participation.
Disclosure of unlabeled use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Accessibility
This activity was produced through educational grant funding received before the 2025 EU accessibility Act was released. Springer Health+ IME is committed to providing equal access and equal opportunity to people with diverse abilities.
